KYMR Kymera Therapeutics, Inc.
Healthcare$80.77+2.38%ClosedMarket Cap: $6.64B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$118.06
Target (Median)
$118.50
Target Range
$90.00 - $138.00
Upside from current price: 46.2%
Rating Distribution
5 Strong Buy18 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-03 | UBS | maintain | Buy | Buy |
| 2026-03-02 | Stephens & Co. | maintain | Overweight | Overweight |
| 2026-03-02 | Citigroup | maintain | Buy | Buy |
| 2026-02-26 | BTIG | maintain | Buy | Buy |
| 2026-02-26 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-01-28 | Barclays | maintain | Overweight | Overweight |
| 2026-01-15 | BTIG | maintain | Buy | Buy |
| 2026-01-06 | Wolfe Research | downgrade | Peer Perform | Outperform |
| 2025-12-22 | B. Riley Securities | maintain | Buy | Buy |
| 2025-12-16 | RBC Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.30 | $39.5M | 17 |
| Sun Dec 31 | $-4.70 | $39.4M | 15 |
| Mon Dec 31 | $-4.81 | $48.3M | 10 |
| Tue Dec 31 | $-3.84 | $211.3M | 6 |